Healthcare Portfolio

We believe our portfolio best meets the varied and often complex needs of patients, employees and investors. Avanti Therapeutics is positioned to lead in innovation, partner with others and offer solutions to patients across a broad healthcare spectrum. In addition, a diverse portfolio reduces financial risk, bringing greater value to those who invest in our company.

Our innovative portfolio of drug commercialization platforms, focuses on science-based healthcare sectors that are growing rapidly, reward innovation, and enhance the lives of patients. Avanti Therapeutics is developing innovative patent-protected product pipelines using its innovative platform technology to achieve leading positions in each of these key areas:

• Aayush-O- : Oncology:           Product engine for commercializing detection, monitoring and targeted therapy products- innovative personalized medicines for cancer treatment
• Aayush-CV: Cardiovascular:            Product engine for commercializing detection, monitoring and targeted therapy products for Cardiovascular diseases.
• Aayush-CNS: CNS:     Product engine for commercializing detection, monitoring and targeted therapy products for central nervous system diseases
• Aayush-RM: Regenerative Medicine:       Product engine for commercializing detection, monitoring and targeted therapy products regenerative medicine
• Aayush- SP: Speciality Pharma:     Innovative products for development of biopharmaceutical products
• Aayush-V: Vaccines:              Development of innovative vaccines
• Aayush-MD: MolecularDiagnostics:           Personalized diagnostic tools to protect against life-threatening diseases

Avanti Therapeutics has completed at least one Proof of Concept study for each of these key areas.